117 related articles for article (PubMed ID: 35292188)
1. Risk factors for lymphatic and hematogenous metastasis after diagnosis of cutaneous Melanoma in Taiwan.
Hsu CC; Lee TL; Lin MH; Liao YH; Liau JY; Sheen YS
J Formos Med Assoc; 2022 Sep; 121(9):1823-1831. PubMed ID: 35292188
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Calomarde-Rees L; García-Calatayud R; Requena Caballero C; Manrique-Silva E; Traves V; García-Casado Z; Soriano V; Kumar R; Nagore E
JAMA Dermatol; 2019 Jun; 155(6):679-687. PubMed ID: 31042264
[TBL] [Abstract][Full Text] [Related]
3. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
4. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of malignant melanoma in Taiwan.
Chen YJ; Wu CY; Chen JT; Shen JL; Chen CC; Wang HC
J Am Acad Dermatol; 1999 Dec; 41(6):945-9. PubMed ID: 10570378
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.
Lee TL; Liao YH; Liau JY; Sheen YS
Sci Rep; 2021 Oct; 11(1):21012. PubMed ID: 34697327
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
12. A single institute's experience on melanoma prognosis: a long-term follow-up.
Dika E; Chessa MA; Veronesi G; Ravaioli GM; Fanti PA; Ribero S; Tripepi G; Gurioli C; Traniello Gradassi A; Lambertini M; Patrizi A
G Ital Dermatol Venereol; 2018 Jun; 153(3):326-332. PubMed ID: 28079338
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma.
Berghe AS; Cobzac G; Dindelegan G; Șenilă SC; Baican CI; Solomon CM; Rogojan L; Leucuța DC; Drugan TC; Bolboacă SD
Exp Ther Med; 2021 Jul; 22(1):730. PubMed ID: 34055049
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
15. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
16. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of brain metastases in cutaneous head and neck melanoma.
Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ
Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]